Corporate News

Kooth (AIM:KOO), the UK's leading digital mental health platform, announces the appointment of Stifel Nicolaus Europe Limited as joint corporate broker, to work alongside Panmure Gordon, the Company's existing Nominated Adviser and Broker, with immediate effect.

 

Kooth plc	[email protected]
Tim Barker, CEO
Sanjay Jawa, CFO
Panmure Gordon, Nominated Adviser and Joint Broker
Corporate Finance: Dominic Morley, Alisa MacMaster	+44 (0) 20 7886 2500
Corporate Broking: Erik Anderson
Stifel Nicolaus Europe Limited, Joint Broker	+44 (0) 20 7710 7600
Ben Maddison, Nick Adams, Nicholas Harland, Richard Short
FTI Consulting	[email protected]
Jamie Ricketts, Alex Shaw, Charlotte Stephen, Usama Ali

 

About Kooth plc: 

Kooth (AIM:KOO) is the UK's leading digital mental health platform. Our mission is to provide accessible and safe spaces for everyone to achieve better mental health. Our platform is clinically robust and accredited to provide a range of therapeutic support and interventions. All our services are predicated on easy access to make early intervention and prevention a reality.

Our four services are:

• Kooth: for children and young persons
• Kooth Student: for university and higher-education students
• Kooth: for Adults
• Kooth Work: for employees
  

Kooth is a fully safeguarded and pre-moderated community with a library of peer and professional created content, alongside access to experienced online counsellors. There are no thresholds for support and no waiting lists. Currently, Kooth sees over 4,000 logins a day.

For adults, Kooth operates across distinct locations and serves specific cohorts, including parents, teachers, victims of crime, and those who have suffered from or continue to experience domestic violence. It is also offered as a benefit by a number of corporate organisations delivering anonymous digital mental health support services to employees.

Kooth is the only digital mental health provider to hold a UK-wide accreditation from the British Association of Counselling and Psychotherapy (BACP).